DNA Aptamer-based detection of prostate cancer

Pawan Jolly, Nello Formisano, Pedro Estrela

Research output: Contribution to journalReview article

26 Citations (Scopus)
75 Downloads (Pure)

Abstract

The use of aptamers in biosensing has attracted considerable attention as an alternative to antibodies because of their unique properties such as long-term stability, cost-effectiveness and adjustability to various applications. Among cancers, the early diagnosis of prostate cancer (PCa) is one of the greatest concerns for ageing men worldwide. One of the most commonly used biomarkers for PCa is prostate-specific antigen (PSA), which can be found in elevated levels in patients with cancer. This review presents the gradual transition of research from antibody-based to aptamer-based biosensors, specifically for PSA. A brief description on aptamer-based biosensing for other PCa biomarkers is also presented. Special attention is given to electrochemical methods as analytical techniques for the development of simple, sensitive and cost-effective biosensors. The review also focuses on the different surface chemistries exploited for fabrication and their applications in clinical samples. The use of aptamers represents a promising tool for the development of point-of-care biosensors for the early detection of prostate cancer. In view of the unmatched upper hand of aptamers, future prospects are also discussed, not only in the point-of-care format but also in other novel applications.
Original languageEnglish
Pages (from-to)77-89
Number of pages13
JournalChemical Papers
Volume69
Issue number1
Early online date28 Nov 2014
DOIs
Publication statusPublished - Jan 2015

Fingerprint

Nucleotide Aptamers
Biosensors
Prostatic Neoplasms
DNA
Prostate-Specific Antigen
Antigens
Biosensing Techniques
Antibodies
Point-of-Care Systems
Early Detection of Cancer
Biomarkers
Tumor Biomarkers
Cost effectiveness
Surface chemistry
Aging of materials
Fabrication
Cost-Benefit Analysis
Costs
Costs and Cost Analysis
Research

Keywords

  • DNA aptamers
  • Biosensor
  • Electrochemical impedance spectroscopy
  • Prostate specific antigen
  • Prostate cancer
  • Surface chemistry

Cite this

DNA Aptamer-based detection of prostate cancer. / Jolly, Pawan; Formisano, Nello; Estrela, Pedro.

In: Chemical Papers, Vol. 69, No. 1, 01.2015, p. 77-89.

Research output: Contribution to journalReview article

Jolly, Pawan ; Formisano, Nello ; Estrela, Pedro. / DNA Aptamer-based detection of prostate cancer. In: Chemical Papers. 2015 ; Vol. 69, No. 1. pp. 77-89.
@article{d010dbe53a634b7e89be4850b50002af,
title = "DNA Aptamer-based detection of prostate cancer",
abstract = "The use of aptamers in biosensing has attracted considerable attention as an alternative to antibodies because of their unique properties such as long-term stability, cost-effectiveness and adjustability to various applications. Among cancers, the early diagnosis of prostate cancer (PCa) is one of the greatest concerns for ageing men worldwide. One of the most commonly used biomarkers for PCa is prostate-specific antigen (PSA), which can be found in elevated levels in patients with cancer. This review presents the gradual transition of research from antibody-based to aptamer-based biosensors, specifically for PSA. A brief description on aptamer-based biosensing for other PCa biomarkers is also presented. Special attention is given to electrochemical methods as analytical techniques for the development of simple, sensitive and cost-effective biosensors. The review also focuses on the different surface chemistries exploited for fabrication and their applications in clinical samples. The use of aptamers represents a promising tool for the development of point-of-care biosensors for the early detection of prostate cancer. In view of the unmatched upper hand of aptamers, future prospects are also discussed, not only in the point-of-care format but also in other novel applications.",
keywords = "DNA aptamers, Biosensor, Electrochemical impedance spectroscopy, Prostate specific antigen, Prostate cancer, Surface chemistry",
author = "Pawan Jolly and Nello Formisano and Pedro Estrela",
year = "2015",
month = "1",
doi = "10.1515/chempap-2015-0025",
language = "English",
volume = "69",
pages = "77--89",
journal = "Chemical Papers",
issn = "0366-6352",
publisher = "De Gruyter",
number = "1",

}

TY - JOUR

T1 - DNA Aptamer-based detection of prostate cancer

AU - Jolly, Pawan

AU - Formisano, Nello

AU - Estrela, Pedro

PY - 2015/1

Y1 - 2015/1

N2 - The use of aptamers in biosensing has attracted considerable attention as an alternative to antibodies because of their unique properties such as long-term stability, cost-effectiveness and adjustability to various applications. Among cancers, the early diagnosis of prostate cancer (PCa) is one of the greatest concerns for ageing men worldwide. One of the most commonly used biomarkers for PCa is prostate-specific antigen (PSA), which can be found in elevated levels in patients with cancer. This review presents the gradual transition of research from antibody-based to aptamer-based biosensors, specifically for PSA. A brief description on aptamer-based biosensing for other PCa biomarkers is also presented. Special attention is given to electrochemical methods as analytical techniques for the development of simple, sensitive and cost-effective biosensors. The review also focuses on the different surface chemistries exploited for fabrication and their applications in clinical samples. The use of aptamers represents a promising tool for the development of point-of-care biosensors for the early detection of prostate cancer. In view of the unmatched upper hand of aptamers, future prospects are also discussed, not only in the point-of-care format but also in other novel applications.

AB - The use of aptamers in biosensing has attracted considerable attention as an alternative to antibodies because of their unique properties such as long-term stability, cost-effectiveness and adjustability to various applications. Among cancers, the early diagnosis of prostate cancer (PCa) is one of the greatest concerns for ageing men worldwide. One of the most commonly used biomarkers for PCa is prostate-specific antigen (PSA), which can be found in elevated levels in patients with cancer. This review presents the gradual transition of research from antibody-based to aptamer-based biosensors, specifically for PSA. A brief description on aptamer-based biosensing for other PCa biomarkers is also presented. Special attention is given to electrochemical methods as analytical techniques for the development of simple, sensitive and cost-effective biosensors. The review also focuses on the different surface chemistries exploited for fabrication and their applications in clinical samples. The use of aptamers represents a promising tool for the development of point-of-care biosensors for the early detection of prostate cancer. In view of the unmatched upper hand of aptamers, future prospects are also discussed, not only in the point-of-care format but also in other novel applications.

KW - DNA aptamers

KW - Biosensor

KW - Electrochemical impedance spectroscopy

KW - Prostate specific antigen

KW - Prostate cancer

KW - Surface chemistry

UR - http://dx.doi.org/10.1515/chempap-2015-0025

U2 - 10.1515/chempap-2015-0025

DO - 10.1515/chempap-2015-0025

M3 - Review article

VL - 69

SP - 77

EP - 89

JO - Chemical Papers

JF - Chemical Papers

SN - 0366-6352

IS - 1

ER -